Abstract

BPI24-022: Our Approach to Patient Selection for Polatuzumab-Based Therapy in Advanced Diffuse Large B-Cell Lymphoma.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call